How to Help Your College Freshman Avoid Depression
From stress due to academic requirements to being away from home for the first time, college presents a host of […]
From stress due to academic requirements to being away from home for the first time, college presents a host of […] Both caffeine and tobacco can contribute to the manifestation of anxiety in different ways, particularly by contributing to the physiological […] (HealthDay)—For patients with acute myocardial infarction (AMI), mortality rates differ based on characteristics associated with race, according to a study […] Soaring number of patients are facing six-week waits for crucial NHS tests and scans amid crippling staff shortages at hospitals […] MONDAY, Nov. 5, 2018 — In addition to fear of pain and suffering, Americans worry about cancer-related expenses, according to […] New research adds to a growing body of evidence suggesting that the expansion of Medicaid under the Affordable Care Act […] Is your GP surgery at risk of closure? Map reveals where 2.5 MILLION patients could see their practice disappear ‘because […] September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […] Many patients want more information on the medicines they’re prescribed and greater say in the brands they use, the first […] Patient engagement requires creativity, trust building and flexibility from health care providers, especially when treating high-need patients, a new Stanford […]patients
How to Help Your College Freshman Avoid Depression
Can Coffee and Nicotine Contribute to Your Anxiety?
Characteristics of black AMI patients impact mortality rate
Soaring number of patients are facing six-week waits for NHS tests
Poll: Patients, Caregivers Worry About Cost of Cancer Care
Emergency department visits by uninsured patients drop in Illinois after Medicaid expansion
2.5 MILLION patients could see their GP surgeries disappear
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata
New study finds patients want more information about their medicine
Researcher discusses engaging high-need patients in intensive outpatient programs
Copyright © 2025